Alanna Rennie is a senior associate in Baker McKenzie's Sydney office where she focuses on private M&A, corporate advisory and intellectual property licensing.
She is admitted in Australia and holds a bachelor of laws (honours) from Bond University and Masters in Chinese Law from Tsinghua University.
She has played a central role in initiating the firm's global plant innovation practice and has guided companies in China and Australia on plant variety registration, licensing and enforcement.
Representative Legal Matters
- Advised GlaxoSmithKline on a global restructure and joint venture with Pfizer combing their consumer healthcare businesses.
- Advised Mitsubishi UFJ Trust and Banking Corporation's acquisition of Colonial First State Global Asset Management from Commonwealth Bank of Australia for AUD 4.1 billion.
- Advised foreign pension fund on acquisition of several fruit tree orchards in Australia.
- Advised African Import-Export Bank (Afreximbank) on its African Medical Centres of Excellence Project across Africa, including a clinical services agreement with King's College Hospital, London.
- Advised Afreximbank on its African Quality Assurance Centre in Nigeria for agricultural products, including its long term services agreement with Bureau Veritas.
- Advised Enviro-Tech start-up on capital raising, intellectual property licensing, supply and research agreements and regulation.
- Advised multinational security group Securitas' acquisition of Staysafe security electronic monitoring business in Australia.
- Advised several major Australian and New Zealand breeding companies on plant variety licensing and pro forma documentation.
- Advised various on Plant Breeder's Rights applications in China and Australia.
- Advised Major US breeding company on enforcement strategy in China.
- New South Wales (2018)
- High Court of Australia (2018)
- Tsinghua University (Masters in Chinese Law) (2019)
- Bond University (Bachelor of Laws, honours) (2016)
Reforms underway for Medicinal Cannabis in Australia
Australian Government Reviews Regulatory Framework for Medicinal Cannabis Cultivation, Production and Manufacture
The Path is Open for Gene Editing of Plants and Animals in Australia